Keith Kummerfeld C.'s most recent trade in Arcturus Therapeutics Holdings Inc was a trade of 30,000 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on Dec. 15, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Arcturus Therapeutics Holdings | Keith Kummerfeld C. | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2023 | 30,000 | 30,000 | - | - | Employee Stock Option (right to buy) | |
| Arcturus Therapeutics Holdings | Keith C. Kummerfeld | See Remarks | Sale of securities on an exchange or to another person at price $ 35.00 per share. | 14 Jul 2023 | 6,968 | 950 (0%) | 0% | 35 | 243,880 | Common Stock |
| Arcturus Therapeutics Holdings | Keith C. Kummerfeld | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.04 per share. | 14 Jul 2023 | 4,500 | 5,450 (0%) | 0% | 9.0 | 40,680 | Common Stock |
| Arcturus Therapeutics Holdings | Keith C. Kummerfeld | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jul 2023 | 4,500 | 21,000 | - | - | Employee Stock Option (right to buy) | |
| Arcturus Therapeutics Holdings | Keith C. Kummerfeld | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.99 per share. | 14 Jul 2023 | 1,437 | 6,887 (0%) | 0% | 5.0 | 7,171 | Common Stock |
| Arcturus Therapeutics Holdings | Keith C. Kummerfeld | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jul 2023 | 1,437 | 7,126 | - | - | Employee Stock Option (right to buy) | |
| Arcturus Therapeutics Holdings | Keith C. Kummerfeld | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.12 per share. | 14 Jul 2023 | 1,031 | 7,918 (0%) | 0% | 14.1 | 14,558 | Common Stock |
| Arcturus Therapeutics Holdings | Keith C. Kummerfeld | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jul 2023 | 1,031 | 7,938 | - | - | Employee Stock Option (right to buy) | |
| Arcturus Therapeutics Holdings | Keith C. Kummerfeld | See Remarks | Sale of securities on an exchange or to another person at price $ 28.18 per share. | 17 Apr 2023 | 6,968 | 950 (0%) | 0% | 28.2 | 196,358 | Common Stock |
| Arcturus Therapeutics Holdings | Keith C. Kummerfeld | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2023 | 4,500 | 25,500 | - | - | Employee Stock Option (right to buy) | |
| Arcturus Therapeutics Holdings | Keith C. Kummerfeld | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.04 per share. | 17 Apr 2023 | 4,500 | 6,481 (0%) | 0% | 9.0 | 40,680 | Common Stock |
| Arcturus Therapeutics Holdings | Keith C. Kummerfeld | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2023 | 1,437 | 8,563 | - | - | Employee Stock Option (right to buy) | |
| Arcturus Therapeutics Holdings | Keith C. Kummerfeld | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.99 per share. | 17 Apr 2023 | 1,437 | 7,918 (0%) | 0% | 5.0 | 7,171 | Common Stock |
| Arcturus Therapeutics Holdings | Keith C. Kummerfeld | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.12 per share. | 17 Apr 2023 | 1,031 | 1,981 (0%) | 0% | 14.1 | 14,558 | Common Stock |
| Arcturus Therapeutics Holdings | Keith C. Kummerfeld | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2023 | 1,031 | 8,969 | - | - | Employee Stock Option (right to buy) | |
| Arcturus Therapeutics Holdings | Keith C. Kummerfeld | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2022 | 33,000 | 33,000 | - | - | Employee Stock Option (right to buy) | |
| Arcturus Therapeutics Holdings | Keith C. Kummerfeld | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Dec 2020 | 45,000 | 45,000 | - | - | Stock Option (right to buy) |